InflaRx: On Watch For A Buy During Tax Loss Selling Season

Dec. 14, 2022 2:34 AM ETInflaRx N.V. (IFRX) StockIFRX6 Comments
Amit Ghate
4.85K Followers

Summary

  • IFRX has been beaten down much like many other biotech companies.
  • The company has a lead drug which is being considered for EUA in the US and use in the EU for critical covid.
  • It also is in Phase II studies in other indications.
  • Furthermore, the stock trades near cash and has a strong buy quant rating.
  • I am looking to buy it, if it dips on potential tax loss selling.

Word Tax 2022 on the calculator on documents.Income Statement. paying the tax rate. Taxation, taxes burden.Business and tax concept.

pcess609/iStock via Getty Images

Tax Loss Strategy

There aren't many consistent structural alpha plays remaining in the market, because over time they have been arbitraged out. But one that I think still has some juice is buying certain beaten down stocks

This article was written by

4.85K Followers
I'm a private trader interested in both long and short ideas. My training and background are in engineering including several decades of consulting engineering practice. I endeavor to apply my analytical skills to investing/trading, which I've done for 20+ years and to which I bring a contrarian style. I've also recently become interested in writing and have published editorials at Forbes, PJM, and a few legacy newspapers.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in IFRX over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I actively trade around core positions.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About IFRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on IFRX

Related Stocks

SymbolLast Price% Chg
IFRX
--